Diagnostics (Nov 2022)

Added Value of Ultrasound-Based Multimodal Imaging to Diagnose Hepatic Sclerosed Hemangioma before Biopsy and Resection

  • Feiqian Wang,
  • Kazushi Numata,
  • Hiromi Nihonmatsu,
  • Makoto Chuma,
  • Naomi Ideno,
  • Akito Nozaki,
  • Katsuaki Ogushi,
  • Mikiko Tanab,
  • Masahiro Okada,
  • Wen Luo,
  • Masayuki Nakano,
  • Masako Otani,
  • Yoshiaki Inayama,
  • Shin Maeda

DOI
https://doi.org/10.3390/diagnostics12112818
Journal volume & issue
Vol. 12, no. 11
p. 2818

Abstract

Read online

Imaging methods have the overwhelming advantage of being non-invasive in the diagnosis of hepatic lesions and, thanks to technical developments in the field of ultrasound (US), radiation exposure can also be avoided in many clinical situations. In particular, contrast-enhanced US (CEUS) outperforms other radiological methods in regard to real-time images, repeatability, and prompt reporting and demonstrates relatively few contraindications and adverse reactions. In this study, we reported in detail a rare benign tumor: hepatic sclerosed hemangioma (HSH). We described US-based multimodal imaging (B-flow imaging, US elastography, and Sonazoid CEUS) features of this HSH case. Furthermore, by summarizing the recently published literature on the imaging diagnosis of HSH, we offered readers comprehensive knowledge of conventional imaging methods (CT, MRI) and CEUS in the diagnosis of HSH and preliminarily discussed their mechanism of pathology-based diagnosis. Our multimodal imaging approach may provide a diagnostic strategy for HSH, thus avoiding unnecessary biopsy or resection.

Keywords